$12.73
-0.48 (-3.63%)
Performance
1D
+0.00%
1W
+15.10%
1M
+23.23%
3M
+30.56%
6M
+61.55%
1Y
-12.33%
YTD
-28.80%
Open$12.88
Previous Close$13.21
Day High$13.20
Day Low$12.52
52W High$20.46
52W Low$7.21
Volume—
Avg Volume5.02M
Market Cap2.96B
P/E Ratio17.51
EPS$0.71
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$10.21
Above
SMA 200
$10.82
Above
RSI (14)
63.1
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
10 analysts
Price Target
+176.7% upside
Current
$12.73
$12.73
Target
$35.22
$35.22
$21.76
$35.22 avg
$46.82
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 484.18M | 324.86M | 922.90M |
| Net Income | 139.43M | 84.20M | -95,808,796 |
| Profit Margin | 28.8% | 27.4% | -10.4% |
| EBITDA | 178.67M | 113.89M | -107,012,515 |
| Free Cash Flow | — | — | -83,155,340 |
| Rev Growth | +49.0% | +49.0% | +20.1% |
| Debt/Equity | 0.15 | 0.15 | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |